Permissible Outcomes of Lobe-Specific Lymph Node Dissection for Elevated Carcinoembryonic Antigen in Non-Small Cell Lung Cancer

Background and Objectives: Lobe-specific nodal dissection (L-SND) is currently acceptable for the dissection of early-stage non-small cell lung cancer (NSCLC) but not for cancers of more advanced clinical stages. We aimed to assess the efficacy of L-SND, compared to systemic nodal dissection (SND)....

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroda, Hiroaki, Ichinose, Junji, Masago, Katsuhiro, Takahashi, Yusuke, Nakada, Takeo, Nakao, Masayuki, Okumura, Sakae, Hashimoto, Kohei, Matsuura, Yosuke, Sakakura, Noriaki, Matsushita, Hirokazu, Mun, Mingyon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709178/
https://www.ncbi.nlm.nih.gov/pubmed/34946309
http://dx.doi.org/10.3390/medicina57121365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709178/
https://www.ncbi.nlm.nih.gov/pubmed/34946309
http://dx.doi.org/10.3390/medicina57121365

Ejemplares similares